Norflurane
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Norflurane
- DrugBank Accession Number
- DB13116
- Background
Norflurane is under investigation in clinical trial NCT01673061 (Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage).
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
- Weight
- Average: 102.032
Monoisotopic: 102.009262716 - Chemical Formula
- C2H2F4
- Synonyms
- 1,1,1,2 Tetrafluoroethane
- Norflurane
- Tetrafluoroethane
- External IDs
- Dymel 134A
- Forane 134A
- Genetron 134A
- HFA 134A
- HFA-134-A
- HFA-134A
- HFA-134A PROPELLANT
- HFC-134A
- R-134A
- Solkane 134A
- Suva 134A
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as organofluorides. These are compounds containing a chemical bond between a carbon atom and a fluorine atom.
- Kingdom
- Organic compounds
- Super Class
- Organohalogen compounds
- Class
- Organofluorides
- Sub Class
- Not Available
- Direct Parent
- Organofluorides
- Alternative Parents
- Hydrofluorocarbons / Hydrocarbon derivatives / Alkyl fluorides
- Substituents
- Aliphatic acyclic compound / Alkyl fluoride / Alkyl halide / Hydrocarbon derivative / Hydrofluorocarbon / Organofluoride
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- DH9E53K1Y8
- CAS number
- 811-97-2
- InChI Key
- LVGUZGTVOIAKKC-UHFFFAOYSA-N
- InChI
- InChI=1S/C2H2F4/c3-1-2(4,5)6/h1H2
- IUPAC Name
- 1,1,1,2-tetrafluoroethane
- SMILES
- FCC(F)(F)F
References
- General References
- Not Available
- External Links
- KEGG Drug
- D05208
- PubChem Compound
- 13129
- PubChem Substance
- 347829239
- ChemSpider
- 12577
- 1311560
- ChEMBL
- CHEMBL2104432
- ZINC
- ZINC000008214630
- Wikipedia
- 1,1,1,2-Tetrafluoroethane
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Terminated Treatment Abscesses 1 3 Completed Treatment Asthma 1 2 Completed Treatment Chronic Obstructive Pulmonary Disease (COPD) 2 1 Completed Treatment Asthma 1 1 Completed Treatment Healthy Subjects (HS) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 18.6 mg/mL ALOGPS logP 1.39 ALOGPS logP 1.33 Chemaxon logS -0.74 ALOGPS Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 12.02 m3·mol-1 Chemaxon Polarizability 4.84 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0900000000-53ecfa599700f19df09a Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0900000000-b834ace5cf324b94846a Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-1900000000-6a1cb710ec9dcccd132d Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0900000000-39e533beda2a30187ddb Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0900000000-b9ee21c472fe415264ef Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-03e9-9000000000-401ed9ad67f231e96f04 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 121.8329 predictedDeepCCS 1.0 (2019) [M+H]+ 123.72832 predictedDeepCCS 1.0 (2019) [M+Na]+ 131.41588 predictedDeepCCS 1.0 (2019)
Drug created at October 21, 2016 03:20 / Updated at February 21, 2021 18:54